Chronic heart failure drug on PBS

The angiotensin receptor neprilysin inhibitor sacubitril/valsartanfor (Entresto) will be available on the PBS from 1 June for adults with chronic heart failure (NYHA Class II-IV) with reduced ejection fraction. Minister for Health Greg Hunt, MP, said the listing would benefit more than 60,000 Australians every year who currently pay around $2,000 per year for their prescriptions. ...

Already a member?

Login to keep reading.

© 2021 the limbic